- ‘Most Expensive Drug’ Zolgensma facing new challenge after Two Children Died
- Hair loss and sexual dysfunction added to list of symptoms of long-COVID along with fatigue and brain fog
- Merck diabetes drug Sitagliptin was hit by carcinogenic impurities
- CDC relaxes and reiterates its COVID-19 guidance
- How does NOVAVAX solve the dilemma when COVID-19 vaccine sales plummeted by 90%?
- Scientists develop new antibiotic molecule that kills several superbugs
Over half of the hospitalized cases in Israel are COVID-19 breakthrough infections; in-depth articles explore countermeasures and induce a wide range of highly effective neutralizing antibodies!
The new coronavirus has spread across the world again with the Delta mutant strain, and has caused “breakthrough infections” no longer uncommon. On August 15, the number of COVID-19 patients hospitalized in Israel due to severe illness reached 514, and 59% of them have been fully vaccinated. vaccine. (Note: 68% of people in Israel are fully vaccinated, see the second tweet today for details)
This ratio shocked scientists. It is very necessary to find a broad-spectrum and efficient pan-coronavirus.
On August 18, 2021, the Wang Linfa project team, Director of the Institute of Emerging Infectious Diseases at the Duke-National University of Singapore School of Medicine, published a blockbuster article in the New England Journal of Medicine (NEJM) that attracted a lot of attention.
This study found that after SARS survivors received the BNT162b2 vaccination in 2003, they produced SARS-CoV-2 Alpha, Beta, Delta mutant strains and SARS-CoV, as well as three bat coronaviruses RaTG13, SHC014 and WIV1. There are broad-spectrum neutralizing antibodies against two pangolin coronaviruses, GD-1 and GX-P5L, and the serum neutralizing activity is very significant.
This study is a well-deserved blockbuster study, because SARS-CoV is close to WIV1, and SARS-CoV-2 is close to RaTG13 and pangolin coronavirus. Therefore, after previous SARS-CoV infection and SARS-CoV-2 vaccination, it can be seen These patients have developed ultra-broad-spectrum neutralizing antibodies against a variety of coronaviruses, which provides important inspiration for the development of pan-coronavirus vaccines to prevent the cross-species transmission of new coronaviruses. This is also the content of my current research.
This is the end of the interpretation of this issue, and I hope to inspire you; if you need to read the full text of this paper, you can reply to “20210819” to get it.
Over half hospitalized cases in Israel are COVID-19 breakthrough infections
(source:internet, reference only)